Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharmaceutical Discuss Legislative Changes & Supply Chain Strategy

Share Article

Senior supply chain directors from Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharma and other top pharmaceutical companies will join together June 29-30 in Chicago. They will join to discuss key supply chain strategies with an elite invite-only audience of their peers over 2 days.

Senior supply chain directors from Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharma and other top pharmaceutical companies will join together June 29-30 in Chicago for a high-level discussion of supply chain strategy and legislative changes on the Pharmaceutical Track of the Healthcare & Life Sciences Supply Chain Summit.

The Summit will draw together senior supply chain executives from both pharmaceutical and medical devices companies for a cross-industry discussion of key supply chain strategies and issues. Key focus topics include globalizing the healthcare supply chain, California ePedigree requirements, cold chain strategies, security, healthcare reform and much more.

Complimentary passes to the event are available to supply chain executives currently working for a pharmaceutical or medical devices company. These can be reserved online at: http://www.eyefortransport.com/healthcare/register.shtml

A limited number of sponsorship opportunities are also available for the Summit to companies that provide a supply chain or logistics service or solution to the healthcare & life sciences industry.

The event is hosted by eyefortransport, a news, research, though leadership and events organization with over 11 years of experience in the supply chain and logistics industry.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Emma Miller
eyefortransport
1-800-814-3459 ext. 7178
Email >

Toby Spencer
eyefortransport
1-800-814-3459 ext. 7168
Email >
Visit website